Trial intelligence / Profile preview

Propofol vs Midazolam for Endoscopy Sedation in Cirrhosis

NCT00906139Phase 4Unknown

Sponsor
Federal University of São Paulo
Start
Mar 2008
Primary completion
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of propofol (2 arms), sponsored by Federal University of São Paulo. Primary endpoints: Efficacy (completion of procedures) at 3 months, Complications at 3 months and 1 more. Status: unknown.

02

Drugs

propofol

Beyond the preview

Go deeper on NCT00906139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00906139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call